Effect of low molecular weight organic compound sodium 2-(2-hydroxyphenoxy)acetyl)-L-prolinate on rat gastric secretion stimulated by carbachol-Reference-Cited by-同舟云学术

Effect of low molecular weight organic compound sodium 2-(2-hydroxyphenoxy)acetyl)-L-prolinate on rat gastric secretion stimulated by carbachol

Published:2014 Issue:3 Volume:68 Page:60-64
ISSN:1728-2748
Container-title:Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology
language:
Short-container-title:BTSNUKSB

Author:

Markevych A.¹,Bogun L.¹,Harchenko O.¹,Kudryavtsev K.²

Affiliation:

1. Taras Shevchenko National University of Kyiv

2. Lomonosov Moscow State University

Abstract

Тto investigate the effects of low molecular organic compound (LMOC) on gastric acid secretion (GAS), pepsin output and the activity of Н+,К+-ATPase in the conditions of carbachol stimulation. GAS stimulated by carbachol was measured by method of isolated perfused stomach, pepsin output was analyzed by colorimetric method for 120 minutes and the activity of Н+,К+-ATPase was assessed spectrophotometrically by the level of anorganic phosphate on 20 white laboratory rats. GAS, pepsin output and the Н+,К+-ATPase activity were decreased under the carbachol stimulation after injection of LMOC. LMOC decreases the gastric acid and pepsin secretion in terms of carbachol stimulation. The inhibition of Н+,К+-ATPase activity is considered as mechanism of antisecretory property of LMOC.

Publisher

Taras Shevchenko National University of Kyiv

Subject

Applied Mathematics,General Mathematics

Reference17 articles.

1. Shi S. Proton pump inhibitors: an update of their clinical use and pharmacokinetics / S. Shi, U. Klotz // Eur J Clin Pharmacol. – 2008. – № 64. – P. 935–951.

2. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis / C. Hutchinson [et. al] // Gut. – 2007. – № 56 (9). – P. 1291–1295.

3. Proton pump inhibitors and risk for recurrent Clostridium difficile infection / A. Linsky [et. al] // Arch Intern Med. – 2010. – № 170 (9). – P. 772–778.

4. Long-term proton pump inhibitor therapy and risk of hip fracture / Y. Yang [et. al] // JAMA. – 2006. – № 296 (24). – P. 2947–2953.

5. Use of proton pump inhibitors and mortality among institutionalized older people / J. Bell [et.al] // Arch Intern Med. – 2010. – № 170 (17). – P. 1604–1605.